Artificial Intelligence Care Coach for Dementia Caregivers

Overseen by Cameron Gettel

Age: 65+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Yale University

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial is testing a computer program that helps caregivers when older adults with memory problems leave the emergency room. The program aims to make the transition from hospital to home smoother by offering guidance and support. It focuses on caregivers because they play a key role in managing the care of these patients.

Research Team

Cameron Gettel

Principal Investigator

Yale University

Eligibility Criteria

This trial is for caregivers of older adults aged 65 or above with dementia or new cognitive impairment identified during an ED visit. Participants must speak English or Spanish, be discharged after an ED visit, and have a smart device with internet to use the NeuViCare AI services. Those showing signs of delirium are not eligible.

Inclusion Criteria

I am 65 or older and have been diagnosed with dementia or noticed new memory problems.

Possession of a smart device (either a phone, tablet, or computer) that has internet access to utilize and interact with NeuViCare AI services

I was recently discharged from the emergency department.

Exclusion Criteria

Evidence of delirium, by the 4-AT screening tool

Treatment Details

Interventions

• NeuViCare application (Artificial Intelligence)

Trial Overview The study is testing the NeuViCare application, which uses artificial intelligence to help manage care transitions after older adults with cognitive impairments are discharged from the emergency department.

Participant Groups

Group I: Intervention (NeuViCare AI) Experimental Treatment 1 Intervention

An anticipated 55 participants will be part of the Intervention arm participants and will engage with NeuViCare AI, including all variations of its 5 components described further below.

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials

1,963

Recruited

3,046,000+

Nancy J. Brown

Yale University

Chief Medical Officer since 2020

MD from Yale School of Medicine

Peter Salovey

Yale University

Chief Executive Officer since 2013

PhD in Psychology from Yale University

West Health Institute

Collaborator

Trials

1

Recruited

60+

National Institute on Aging (NIA)

Collaborator

Trials

1,841

Recruited

28,150,000+

Dr. Richard J. Hodes

National Institute on Aging (NIA)

Chief Executive Officer since 1993

MD from Harvard Medical School

Dr. Marie Bernard

National Institute on Aging (NIA)

Chief Medical Officer

MD from Harvard Medical School

Emergency Medicine Foundation

Collaborator

Trials

18

Recruited

2,200+